Medicare Enrolled

Dr. Clayton Bredlau, M.D.

Cardiovascular Disease · Sarasota, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1215 S EAST AVE STE 303, Sarasota, FL 34239
9413650433
In practice since 2005 (20 years)
NPI: 1124010335 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bredlau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bredlau? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bredlau

Dr. Clayton Bredlau is a cardiovascular disease in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Bredlau performed 8,521 Medicare services across 5,415 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bredlau received a total of $5,751 from 37 pharmaceutical and/or device companies across 302 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bredlau is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 10% volume in FL$ $5,751 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,521
Medicare services
Top 10% in FL for cardiovascular disease
5,415
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~426 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Electrocardiogram (EKG), 12-lead1,488$10$34
Office visit, established patient (30-39 min)1,329$90$218
EKG interpretation and report1,232$6$8
Hospital follow-up visit, moderate complexity431$64$148
Office visit, established patient, complex (40-54 min)404$135$293
Echocardiogram, transthoracic360$139$490
Ultrasound of both sides of head and neck blood flow300$134$397
Hospital follow-up visit, high complexity269$96$212
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days240$20$54
Remote pacemaker monitoring, 90 days227$24$63
Evaluation of cardiac rhythm monitor system, remote up to 30 days227$21$54
Initial hospital admission, high complexity222$138$413
Technetium tc-99m sestamibi, diagnostic, per study dose217$90$236
Ultrasound of one side of head and neck blood flow167$80$254
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days152$17$49
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days151$9$29
Regadenoson injection (Lexiscan) for heart stress test136$42$115
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician118$48$142
Programming of dual lead pacemaker system116$60$129
Nuclear medicine studies of heart muscle at rest and with stress and spect110$326$942
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days85$29$90
Programming of multiple lead implantable defibrillator system60$82$184
Complete ultrasound of abdomen and pelvis artery and vein blood flow58$197$548
Injection, dipyridamole, per 10 mg55$2$3
New patient office visit, complex (60-74 min)44$169$415
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts41$136$372
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes35$10$100
Critical care, each additional 30 minutes33$88$251
Ultrasound study of arm or leg veins with compression and maneuvers27$140$384
New patient office visit (45-59 min)22$108$332
Cardiac catheterization21$173$640
Office visit, established patient (20-29 min)20$68$149
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician19$17$45
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician19$11$30
Ultrasound of leg arteries or artery grafts18$158$493
Emergency department visit, high complexity17$146$362
Hospital discharge management, 30+ min16$93$217
Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel12$519$1,748
Critical care, first 30-74 min12$174$564
Ultrasound of leg arteries at rest and after exercise11$123$324
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.8% high complexity
12.2% medium
77.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,751
Total received (2018-2024)
Avg $822/year across 7 years
Top 36% in FL for cardiovascular disease
37
Companies
302
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,751 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$688
2023
$649
2022
$890
2021
$953
2020
$635
2019
$951
2018
$985

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$818
PFIZER INC.
$600
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$553
AstraZeneca Pharmaceuticals LP
$547
Amgen Inc.
$367
Boston Scientific Corporation
$349
ABIOMED
$302
Boehringer Ingelheim Pharmaceuticals, Inc.
$272
E.R. Squibb & Sons, L.L.C.
$250
Janssen Pharmaceuticals, Inc
$161
Actelion Pharmaceuticals US, Inc.
$142
Regeneron Healthcare Solutions, Inc.
$138
Merck Sharp & Dohme Corporation
$135
SANOFI-AVENTIS U.S. LLC
$132
Abbott Laboratories
$125
Kestra Medical Technology Services, Inc.
$95
Alnylam Pharmaceuticals Inc.
$94
Philips Electronics North America Corporation
$93
BOSTON SCIENTIFIC CORPORATION
$68
Merck Sharp & Dohme LLC
$66
Medtronic Vascular, Inc.
$53
Bayer HealthCare Pharmaceuticals Inc.
$43
Janssen Scientific Affairs, LLC
$32
Allergan Inc.
$32
Cardiovascular Systems Inc.
$32
PORTOLA PHARMACEUTICALS, INC.
$30
Braemar Manufacturing, LLC
$28
Edwards Lifesciences Corporation
$24
Novo Nordisk Inc
$22
Daiichi Sankyo Inc.
$22
ACIST MEDICAL SYSTEMS, INC.
$19
Coala Life Inc
$19
Roche Diagnostics Corporation
$19
Noden Pharma USA Inc
$19
Amarin Pharma Inc.
$19
Preventice Services, LLC
$15
Bardy Diagnostics, Inc.
$15
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
(5044) MCOT · Assure WCD · Azure · BEVYXXA · BG Mini Plus · BRILINTA · BYSTOLIC · CAMZYOS · CVI SYSTEMS · Cardiac Monitoring Suite · CareLink · Carnation Ambulatory Monitor · Coala Heart Monitor · Coronary Orbital Atherectomy System · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · INJECTAFER · Impella · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LifeVest · MULTAQ · Mitra Clip system · MitraClip System · ONPATTRO · OPSUMIT · POC CoaguChek Meters · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · Repatha · Rybelsus · Strips and Accessories · TEKTURNA · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $67 per 100 Medicare services performed
Looking for a cardiovascular disease in Sarasota?
Compare cardiovascular diseases in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
79
Per 100K population
17.6
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bredlau is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bredlau experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Bredlau performed 1,488 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bredlau receive payments from pharmaceutical companies?
Yes. Dr. Bredlau received a total of $5,751 from 37 companies across 302 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bredlau's costs compare to other cardiovascular diseases in Sarasota?
Dr. Bredlau's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bredlau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →